Login

Progression to Insulin Therapy in Patients With Type 2 Diabetes - Dr. Peter Kokkinos, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Progression to Insulin Therapy in Patients With Type 2 Diabetes

Recent Videos

00:10:00
How LRT Capital's Lucas Krupinski Combines Economic Moats and Quant Discipline for Long-Term Outperformance|Mr. Tomicki,CEO,LRT Capital
00:10:00
AlphaBot Revolutionizes Alternative Investment Research with 10x Efficiency and Seamless Multi-Asset Integration at a Fraction of the Cost|Dmitri Alexeev,CIO,Man Group
00:10:00
Harcourt’s Strategy-Focused Fund of Hedge Funds Outperforms with Precision Manager Selection and Unmatched Fee Efficiency|Ilario Scasascia,ED,Vontobel Asset Management AG
00:10:00
Defying Convention with a Systematic Market Timing Strategy That Thrives in Volatility|Heeten H. Doshi,Founder,Doshi Capital
00:10:00
 Exploiting market inefficiencies in undervalued and overlooked African markets|André Steyn,CEO,Steyn Capital
00:10:00
Europe’s Independent Hedge Fund Powerhouse with a Disciplined Edge and Global Reach|Dr Werner Goricki ,CIO,Prime Capital
00:10:00
A Quantitative Edge in China A-Shares and Global Access via Hong Kong|Bo Huang,President,Jasper Capital
00:10:00
Uncorrelated Returns, Predictable Yields: How Laureola’s Life Settlement Strategy Offers Stability and Alpha in Volatile Markets| Tony Bremness,CFA,Laureola Advisors
00:10:00
Why 2022 Marked the Greatest Asset Raising Environment in Hedge Fund History—and How Managers Can Win Big at Cap Intro Events|Don Steinbrugge,CEO,Agecroft Partners
00:10:00
John Katzman Urges EdTech Industry to Rethink Assumptions, Use Data for Support—Not Surveillance|John Katzman, Ceo, Noodle
00:10:00
Pioneering ESG-Driven Alpha Through Data, Discipline, and Sustainable Development Themes|Larry Abele ,CEO,Auriel Capital Management LLP
00:10:00
Mastering Volatility and Skew to Deliver Rare Alpha in Crowded, Convex Markets|Nigol Koulajian,CIO,AlphaQuest
00:10:00
Blending Quantitative Precision and Trading Experience to Navigate Japan’s Markets with Systematic Edge|Aman Oberoi,CEO,K2Q Capital
00:10:00
Contrarian UK Equity Specialists Unlocking Asymmetric Value in a Post-Brexit Market|Alyx Wood,CIO,Kernow Asset Management
00:10:00
Revolutionizing Art Investment Through Technology, Transparency, and Blue-Chip Access|Tony Dalwood,CEO,Gresham House Ventures
00:10:00
Empowering Global Investment Managers with Infrastructure, Compliance, and Expertise|Clayton Heijman,CEO,Privium Fund Management

Suggestions

00:10:00
Transitioning Mobility Towards Electrification and Circular Economy for Climate Mitigation | Renato Mazzoncini, CEO, A2A Life Company.
00:10:00
Johanna Barr of Advent International Shares Insights on Private Equity Trends and Opportunities at IPM Conference|Johanna Barr - Managing Director, Advent International
00:10:00
We are devoted to our clients and it's reflected by our tenure, scale, and recognition as the industry's fastest growing target date suite. Our dedication to clients is matched by our commitment to our community. flexPATH Strategies is pleased to fundrais
00:10:00
Unlock Financial Freedom with the Infinite Banking Concept
00:10:00
Terra Firma's Guy Hands on Theresa May's Business Policies and the U.K. Economy | Guy Hands, Chairman, Terra Firma Capital Partners.
00:10:00
Ultra Lithium Reports Promising Drill Results and Eyes Strategic Partnerships
00:10:00
John Zhao Discusses Global Interdependence and China's Role in Digital Transformation | Zhang Lei, CEO , Hillhouse Capital Group.
00:10:00
Navigating the Polish Wine Market: Insights from Ambra SA President Robert Ogór | Robert Ogór, President , AMBRA SA.
00:10:00
Unlock Financial Freedom with Expert Guidance from Kingdom Financial
00:10:00
Bilfinger CEO Schulz Talks Full-Year Earnings and Market Pressures | Thomas Schulz - CEO of Bilfinger
00:10:00
Insights from Aurelius Technologies Bhd Equity Sales Webinar: Preparing for Bursa Malaysia Main Market Listing | Loh Hock Chiang - CEO of Aurelius Technologies Berhad
00:10:00
Abingdon Health CEO Chris Yates Discusses Interim Results & Growth Outlook | Chris Yates, CEO, Abingdon Health PLC.

© 2017 - Neuhu+